Total Payments
$937.23
2024 Payments
$215.08
Companies
14
Transactions
44
Medicare Patients
12,022
Medicare Billing
$1.3M
Payment Breakdown by Category
Food & Beverage$937.23 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $937.23 | 44 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Amgen Inc. | $381.59 | 21 | $0 (2022) |
| Veryan Medical Incorporated | $112.17 | 1 | $0 (2024) |
| CARDIVA MEDICAL, INC. | $88.04 | 1 | $0 (2024) |
| Abbott Laboratories | $75.23 | 4 | $0 (2021) |
| Novartis Pharmaceuticals Corporation | $65.64 | 4 | $0 (2019) |
| Boston Scientific Corporation | $63.26 | 4 | $0 (2019) |
| ABIOMED | $27.69 | 1 | $0 (2017) |
| SANOFI-AVENTIS U.S. LLC | $23.37 | 2 | $0 (2018) |
| Bayer HealthCare Pharmaceuticals Inc. | $22.97 | 1 | $0 (2021) |
| Amarin Pharma Inc. | $21.31 | 1 | $0 (2020) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $215.08 | 3 | Veryan Medical Incorporated ($112.17) |
| 2022 | $131.36 | 6 | Amgen Inc. ($119.67) |
| 2021 | $180.22 | 10 | Amgen Inc. ($82.02) |
| 2020 | $47.81 | 3 | Amgen Inc. ($26.50) |
| 2019 | $68.47 | 4 | Amgen Inc. ($30.44) |
| 2018 | $101.94 | 6 | Amgen Inc. ($78.85) |
| 2017 | $192.35 | 12 | Novartis Pharmaceuticals Corporation ($51.46) |
All Payment Transactions
44 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/25/2024 | CARDIVA MEDICAL, INC. | SAVVYWIRE (Device) | Food and Beverage | In-kind items and services | $88.04 | General |
| Category: DEVICES | ||||||
| 11/22/2024 | Veryan Medical Incorporated | BioMimics 3D Vascular Stent System (Device) | Food and Beverage | In-kind items and services | $112.17 | General |
| Category: Vascular Stent | ||||||
| 02/15/2024 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $14.87 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 09/29/2022 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $22.34 | General |
| Category: Cardiology | ||||||
| 06/30/2022 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $22.34 | General |
| Category: Cardiology | ||||||
| 06/09/2022 | Esperion Therapeutics, Inc. | NEXLETOL (Drug) | Food and Beverage | In-kind items and services | $11.69 | General |
| Category: ANTILIPEMIC AGENTS | ||||||
| 06/08/2022 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $28.75 | General |
| Category: Cardiology | ||||||
| 03/10/2022 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $19.41 | General |
| Category: Cardiology | ||||||
| 01/27/2022 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $26.83 | General |
| Category: Cardiology | ||||||
| 11/04/2021 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $14.61 | General |
| Category: Cardiology | ||||||
| 09/23/2021 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $16.23 | General |
| Category: Cardiology | ||||||
| 07/29/2021 | Bayer HealthCare Pharmaceuticals Inc. | Verquvo (Drug) | Food and Beverage | In-kind items and services | $22.97 | General |
| Category: Cardio-pulmonary | ||||||
| 07/22/2021 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $17.39 | General |
| Category: Cardiology | ||||||
| 07/15/2021 | Abbott Laboratories | Xience Sierra Coronary Stent System (Device) | Food and Beverage | In-kind items and services | $18.83 | General |
| Category: Vascular | ||||||
| 07/02/2021 | Abbott Laboratories | Xience Sierra Coronary Stent System (Device) | Food and Beverage | In-kind items and services | $21.18 | General |
| Category: Vascular | ||||||
| 05/24/2021 | Abbott Laboratories | Xience Sierra Coronary Stent (Device) | Food and Beverage | In-kind items and services | $19.29 | General |
| Category: Vascular | ||||||
| 04/22/2021 | Abbott Laboratories | Xience Sierra Coronary Stent (Device) | Food and Beverage | In-kind items and services | $15.93 | General |
| Category: Vascular | ||||||
| 03/25/2021 | Amgen Inc. | Corlanor (Drug), Repatha | Food and Beverage | In-kind items and services | $15.15 | General |
| Category: Cardiology | ||||||
| 02/04/2021 | Amgen Inc. | Corlanor (Drug), Repatha | Food and Beverage | In-kind items and services | $18.64 | General |
| Category: Cardiology | ||||||
| 07/23/2020 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $12.47 | General |
| Category: Cardiology | ||||||
| 06/11/2020 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $14.03 | General |
| Category: Cardiology | ||||||
| 04/02/2020 | Amarin Pharma Inc. | Vascepa (Drug) | Food and Beverage | In-kind items and services | $21.31 | General |
| Category: Cardiovascular | ||||||
| 09/04/2019 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $14.18 | General |
| Category: CARDIOVASCULAR | ||||||
| 03/05/2019 | Boston Scientific Corporation | WATCHMAN (Device) | Food and Beverage | In-kind items and services | $23.85 | General |
| Category: STRUCTURAL HEART | ||||||
| 02/21/2019 | Amgen Inc. | Corlanor (Drug), Repatha | Food and Beverage | In-kind items and services | $18.09 | General |
| Category: Cardiology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 19 | 2,967 | 3,518 | $469,120 | $248,001 |
| 2022 | 20 | 2,565 | 3,289 | $543,033 | $287,355 |
| 2021 | 18 | 3,081 | 4,150 | $718,821 | $387,471 |
| 2020 | 22 | 3,409 | 4,704 | $838,461 | $422,346 |
Total Patients
12,022
Total Services
15,661
Medicare Billing
$1.3M
Procedure Codes
79
All Medicare Procedures & Services
79 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 533 | 726 | $111,078 | $63,988 | 57.6% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Office | 2023 | 322 | 377 | $99,734 | $55,099 | 55.2% |
| 93880 | Ultrasound of both sides of head and neck blood flow | Office | 2023 | 302 | 310 | $104,470 | $44,134 | 42.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 175 | 251 | $26,104 | $16,480 | 63.1% |
| 78431 | Nuclear medicine studies of blood flow in heart muscle at rest and with stress with concurrent ct scan | Office | 2023 | 184 | 184 | $16,928 | $12,446 | 73.5% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 63 | 84 | $17,220 | $10,917 | 63.4% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 550 | 726 | $18,861 | $7,757 | 41.1% |
| 93926 | Ultrasound of one leg arteries or artery grafts | Office | 2023 | 77 | 80 | $16,320 | $7,471 | 45.8% |
| 93923 | Complete ultrasound study of arm and leg arteries | Office | 2023 | 64 | 65 | $13,130 | $6,317 | 48.1% |
| 78434 | Nuclear medicine study of heart muscle blood flow by pet | Office | 2023 | 184 | 184 | $7,360 | $4,133 | 56.2% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 34 | 34 | $7,990 | $3,862 | 48.3% |
| 93016 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision by physician | Office | 2023 | 184 | 184 | $5,888 | $2,983 | 50.7% |
| 93351 | Ultrasound of heart with continuous electrocardiogram (ecg) during rest, exercise and/or drug induced stress with review and report | Office | 2023 | 17 | 17 | $5,593 | $2,762 | 49.4% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 16 | 16 | $4,672 | $2,349 | 50.3% |
| 93018 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | Office | 2023 | 184 | 184 | $3,864 | $1,969 | 51.0% |
| 93288 | Evaluation of single, dual, multiple lead or leadless pacemaker system | Office | 2023 | 32 | 45 | $2,385 | $1,777 | 74.5% |
| 93971 | Ultrasound study of one arm or leg veins with compression and maneuvers | Office | 2023 | 17 | 19 | $3,078 | $1,723 | 56.0% |
| 93224 | Electrocardiogram (ecg) 2-day continuous with review and report by health care professional | Office | 2023 | 18 | 21 | $2,751 | $1,093 | 39.7% |
| 76705 | Limited ultrasound scan of abdomen | Office | 2023 | 11 | 11 | $1,694 | $742.06 | 43.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 607 | 915 | $140,760 | $81,205 | 57.7% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Office | 2022 | 367 | 424 | $112,360 | $64,526 | 57.4% |
| 93880 | Ultrasound of both sides of head and neck blood flow | Office | 2022 | 293 | 305 | $102,785 | $42,544 | 41.4% |
| 78452 | Nuclear medicine studies of heart muscle at rest and with stress and spect | Office | 2022 | 54 | 54 | $35,739 | $17,435 | 48.8% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 88 | 116 | $23,780 | $15,447 | 65.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 166 | 200 | $20,800 | $13,587 | 65.3% |
About Dr. Gerald Koppes, MD
Dr. Gerald Koppes, MD is a Cardiovascular Disease healthcare provider based in San Antonio, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 11/23/2005. The National Provider Identifier (NPI) number assigned to this provider is 1922081900.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Gerald Koppes, MD has received a total of $937.23 in payments from pharmaceutical and medical device companies, with $215.08 received in 2024. These payments were reported across 44 transactions from 14 companies. The most common payment nature is "Food and Beverage" ($937.23).
As a Medicare-enrolled provider, Koppes has provided services to 12,022 Medicare beneficiaries, totaling 15,661 services with total Medicare billing of $1.3M. Data is available for 4 years (2020–2023), covering 79 distinct procedure/service records.
Ad
Practice Information
- Specialty Cardiovascular Disease
- Location San Antonio, TX
- Active Since 11/23/2005
- Last Updated 08/02/2023
- Taxonomy Code 207RC0000X
- Entity Type Individual
- NPI Number 1922081900
Products in Payments
- Repatha (Biological) $212.18
- Corlanor (Drug) $169.41
- BioMimics 3D Vascular Stent System (Device) $112.17
- SAVVYWIRE (Device) $88.04
- ENTRESTO (Drug) $65.64
- Xience Sierra Coronary Stent System (Device) $40.01
- WATCHMAN (Device) $35.75
- Xience Sierra Coronary Stent (Device) $35.22
- Impella (Device) $27.69
- PRALUENT (Drug) $23.37
- Verquvo (Drug) $22.97
- Vascepa (Drug) $21.31
- CHANTIX (Drug) $18.84
- ACCOLADE (Device) $15.69
- XARELTO (Drug) $14.87
- IMAGEREADY MR-CONDITIONAL PACING SYSTEM (Device) $11.82
- NEXLETOL (Drug) $11.69
- Edarbi (Drug) $10.56
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Cardiovascular Disease Doctors in San Antonio
Robert Chilton, Do, DO
Cardiovascular Disease — Payments: $1.8M
Cardiovascular Disease $1.8M
Dr. Chandrasekhar Kunavarapu, M.d, M.D
Cardiovascular Disease — Payments: $456,612
Cardiovascular Disease $456,612
Eric Stocker, Md, MD
Cardiovascular Disease — Payments: $376,204
Cardiovascular Disease $376,204
Mark Colligan, Md, MD
Cardiovascular Disease — Payments: $198,267
Cardiovascular Disease $198,267
Wassim Choucair, M.d, M.D
Cardiovascular Disease — Payments: $135,616
Cardiovascular Disease $135,616
Dr. Jamil Malik, Md, MD
Cardiovascular Disease — Payments: $105,345
Cardiovascular Disease $105,345